spacer
home > epc > spring 2018 > a winning formula
PUBLICATIONS
European Pharmaceutical Contractor

A Winning Formula

Considerable discussion has been had about the concept of patient centricity in the pharmaceutical community. The industry has taken a collective pause in an effort to re-evaluate longstanding approaches to drug development and commercialisation, with attention being recalibrated on the ultimate goal: making reaching improved health outcomes easier for the patient. This perspective is underpinned by the recognition that what is best for the patient will lead to beneficial outcomes for all stakeholders, including the drug company, the healthcare provider, and supporting community of associated service providers.

A famous quote from former US Surgeon General, C Everett Koop states “Drugs don’t work in people who don’t take them”. Less than one-third of all prescriptions written are estimated to be filled at the pharmacy by patients. Wide-ranging studies have shown medication adherence rates for life-threatening diseases including diabetes, heart disease, and oncology can be as low as 30-40%. With the benefit of interventional techniques and developing technologies, adherence rates have been shown to improve. However, these programmes are not broadly adopted with scale and have not had significant impact decreasing the overall cost of healthcare nor benefitted large populations.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Justin Schroeder is Senior Executive Director of global marketing and design at PCI Pharma Services. He is responsible for global marketing, creative package design, and new account development, with a focus on the development and commercialisation of new products. Justin has over 20 years of experience in outsourced pharma services in various roles, including engineering, project management, marketing, and development. He holds a Bachelor of Science from the School of Packaging at Michigan State University, US, and an MBA in marketing from Northern Illinois University, US. Justin is a certified Packaging Professional from the Institute of Packaging Professionals, US, and is the Vice Chairman of the US Healthcare Compliance Packaging Council.
spacer
Justin Schroeder
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Novo Nordisk Pharmatech A/S signs distribution agreement with DKSH for twelve countries in Asia Pacific

Novo Nordisk Pharmatech A/S and DKSH, have partnered to provide high-quality cGMP quaternary ammonium compounds in twelve countries across Asia Pacific
More info >>

White Papers

Bio/Pharmaceutical Methods: Do your Analytical Methods Hold Up to Regulatory Scrutiny?

Eurofins BioPharma Product Testing

As FDA guidelines evolve and drug products on the market begin to age, bio/pharmaceutical manufacturers face scrutiny of the original methods used to support these products. Therefore, manufacturers must re-evaluate these methods to ensure they comply with current FDA expectations. Some manufacturers are even facing consent decrees imposed by the agency requiring them to bring methods up to current standards within a specified timeframe. This exercise requires significant amounts of time and resources, which many manufacturers do not have since they are focused on getting their next products to market. For that reason, some clients have been turning to Eurofins Lancaster Laboratories for support.
More info >>

 
Industry Events

SMi Presents the 13th Annual Conference: Parallel Trade 2019

5-6 February 2019, Holiday Inn Kensington Forum, London

SMi presents its 13th annual Parallel Trade conference, taking place in London on the 5th-6th of February 2019. As the only parallel trade conference in Europe, this event provides the perfect platform for industry experts from both sides of the coin to come together and share perspectives on the practice of parallel trade.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement